Literature DB >> 22248585

Streptococcal IdeS and its impact on immune response and inflammation.

Ulrich von Pawel-Rammingen1.   

Abstract

Survival of the important bacterial pathogen Streptococcus pyogenes relies on its ability to circumvent the antimicrobial actions of innate and specific immune responses and to modulate the inflammatory responses induced during the course of an infection. Inflammatory processes play key roles during streptococcal pathogenesis and streptococcal infections are accompanied by an intense inflammatory state. As an exclusively human pathogen, S. pyogenes has adapted to the various countermeasures employed by its host to fight bacterial infections, in particular to interfere with the effector functions of immunoglobulin G (IgG). For this purpose, S. pyogenes has evolved an IgG-specific endopeptidase, IdeS, which is highly specific for the lower hinge region of IgG. This review summarizes the current knowledge about this intriguing enzyme as well as its role in inflammation and in the attenuation of human immune responses towards streptococcal infection.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248585      PMCID: PMC6741460          DOI: 10.1159/000332940

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  11 in total

1.  Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

Authors:  David Ermert; Antonin Weckel; Michal Magda; Matthias Mörgelin; Jutamas Shaughnessy; Peter A Rice; Lars Björck; Sanjay Ram; Anna M Blom
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

2.  A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Authors:  Randall J Brezski; Michelle Kinder; Katharine D Grugan; Keri L Soring; Jill Carton; Allison R Greenplate; Theodore Petley; Dorie Capaldi; Kerry Brosnan; Eva Emmell; Sharon Watson; Robert E Jordan
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

Review 3.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 4.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

5.  Engineered protease-resistant antibodies with selectable cell-killing functions.

Authors:  Michelle Kinder; Allison R Greenplate; Katharine D Grugan; Keri L Soring; Katharine A Heeringa; Stephen G McCarthy; Gregory Bannish; Meredith Perpetua; Frank Lynch; Robert E Jordan; William R Strohl; Randall J Brezski
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

6.  Lack of Opsonic Antibody Responses to Invasive Infections With Streptococcus dysgalactiae.

Authors:  Anna Bläckberg; Therese de Neergaard; Inga-Maria Frick; Pontus Nordenfelt; Rolf Lood; Magnus Rasmussen
Journal:  Front Microbiol       Date:  2021-04-27       Impact factor: 5.640

7.  IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus.

Authors:  Cheryl Y M Okumura; Ericka L Anderson; Simon Döhrmann; Dan N Tran; Joshua Olson; Ulrich von Pawel-Rammingen; Victor Nizet
Journal:  MBio       Date:  2013-07-30       Impact factor: 7.867

8.  Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.

Authors:  Ryo Takahashi; Nobuhiro Yuki
Journal:  Sci Rep       Date:  2015-07-21       Impact factor: 4.379

9.  Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes.

Authors:  Haniyeh Aghababa; Yi Tian Ting; Devaki Pilapitiya; Jacelyn M S Loh; Paul G Young; Thomas Proft
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

10.  Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS.

Authors:  Christofer A Q Karlsson; Sofia Järnum; Lena Winstedt; Christian Kjellman; Lars Björck; Adam Linder; Johan A Malmström
Journal:  Mol Cell Proteomics       Date:  2018-03-06       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.